Drawbridge Pharmaceuticals

Drawbridge Pharmaceuticals Overview

Founded 2011
Status Private
Employees 3
Latest Deal Type Later Stage VC (Cancelled)
Latest Deal Amount $25M
Latest Deal Amount
Investors 1

Drawbridge Pharmaceuticals General Information


Operator of a biotechnology company intended to develop innovative neuroactive steroid compounds. The company's neuroactive steroid compound is a fast onset and offset intravenous general anaesthetic and sedative that protects the brain from the harmful effects of insults such as hypoxia and trauma, enabling doctors to reduce cardiovascular depression during the course of critical care situations.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 23 Milton Parade
  • Malvern, Victoria 3144
  • Australia
+61 (03) 0000 0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Drawbridge Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 28-Sep-2017 $25M Cancelled Clinical Trials - Phase 2
3. Angel (individual) 01-Aug-2017 00000 00.000 Completed Clinical Trials - Phase 1
2. Angel (individual) 01-Jul-2016 $1M $1M Completed Startup
1. Grant 01-Jan-2014 $2.69K Completed Startup

Drawbridge Pharmaceuticals Executive Team (3)

Name Title Board Seat Contact Info
Gary Taylor Chief Financial Officer & Secretary
Juliet Goodchild Ph.D Co-founder, Chief Product Officer & Executive Director
Colin Goodchild Ph.D Co-Founder, Chairman & Chief Medical Officer

Drawbridge Pharmaceuticals Board Members (2)

Name Representing Role Since
Colin Goodchild Ph.D Drawbridge Pharmaceuticals Co-Founder, Chairman & Chief Medical Officer 000 0000
David Page Drawbridge Pharmaceuticals Board Member 000 0000

Drawbridge Pharmaceuticals Investors (1)

To view Drawbridge Pharmaceuticals‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Department of State Development, Business and Innovation Government 000 0000 000000 0

Ready to get started?

Request a free trial